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1. Introduction
  Acute lung injury (ALI) is acute hypoxia respiratory 
insufficiency or failure caused by diffused pulmonary 
interstitial and alveolar oedema of pulmonary capillary 
endothelial cells in serious infection, shock, trauma, burns 
and other non cardiac disease process[1].
  Lipopolysaccharide (LPS), the outer membrane of 
composition of Gram negative bacteria can directly or 
indirectly damage alveolar epithelium and pulmonary 
vascular endothelial cells[1], induce a series of lung tissue 
pathological physiological change, and then development 
as the ALI[2]. LPS may induce excessive activation of NF-毷 
beta in lung tissue, participate in a variety of genes related 
to early body defense reaction, such as expression and 
regulation of cell factors, adhesion molecules, inflammation 
medium, in the development process of ALI[3]. Sevoflurane 
is a new type of inhalation anesthetics with characteristics 
of induced quickly and small excitant, has good blood 
dynamics stability, its pretreatment[4] and reprocessing 
effect research become clinical research hot spots in recent 
years. Research shows that sevoflurane pretreatment can 
reduce endotoxin induced acute lung injury, protect lung 
function[5]. Inhalation anesthetics post-processing may be a 
protective scheme for viscera from reperfusion injuries[6].
2. Materials and methods
2.1.  Experimental animal
  Clean grade male SD rats were from Shanghai Weasleyg 
Experimental Animal Co., LTD.. 45 male SD rats of weight 
(272 依 15) g, were randomly divided into three groups, with 
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15 in each, (1) the control group: 0.9% NaCl + 0.9% NaCl; (2) 
the endotoxin (LPS) groups: 0.9% NaCl + LPS; (3) sevoflurane 
groups: 0.9% NaCl + LPS. Rats were moved to anesthesia 
box after 4 h since modeled, with sevoflurane inhalation 
(concentration 2.4%) for l h, during spontaneous breathing.
2.2. Animal model establishment
  With reference to the Chin method[7], 40 mg/kg of 
pentobarbital was injected to rats by intraperitoneal 
injection. After anesthesia, limbs were fixed with high 
cutting teeth on board. By neck shaving, the median 
incision skin was 1 cm long, blunt separation organization was 
conducted to exposure trachea, with reagent extraction by 1 mL
syringe, grafted in 25-gauge needle to puncture trachea; 
LPS or NS to trachea was injected slowly (30 seconds) after 
bubble appeared, suture incisions was performed. All rate 
were then put back to the cage with food and water supply 
freely, using desk lamp to maintain the body temperature at 
37.5 ℃. 
2.3. Tissue samples collection
  The rats were sacrificed after 6 h since injection of LPS 
or NS. Pathology observation was performed under HE 
staining. Total RNA and protein were extracted for mRNA 
and protein detection. Protein expression was determined 
by Westernblot method. Cracking cells was performed with 
cell cracking fluid (Cell Signaling Teehnology company, 
USA), supernatant fluid was exacted after centrifuging, and 
total protein was detected using G-250 staining (total protein
50 毺g for Western blot test).
2.4. Methods
2.4.1. Histotomy
  The lower lobe was processed with 10% formaldehyde 
solution, 70%-100% alcohol gradient dehydration, xylene 
processed for 2 times for embedding, Spliced the wax fixed 
with section at thickness of 5-8 毺m, and then put sample in 
constant temperature box at 45 ℃.
2.4.2. HE staining
  The paraffin was taken off by Xylene, then alcohol from 
high was daaded to low concentration, and finally distilled 
water was added for staining. 
2.4.3. Detection pf mRNA of TNF-毩 and ICAM1 by RT-
PCR
  Total RNA of three groups was extracted with Trizol 
method for reverse transcription, using 毬-actin as 
internal reference. Primer sequence wass: upstream: 
5’- GCTCGTCGTCGACAACGGCTG-3’,downstream: 5’- 
CAAACATGATCTGGGTCATCTTTTC-3’, amplified fragment 
for 353 bp. Rats TNF alpha primer sequence: upstream 
5’- TGAGCACAGAAAGCATGATC-3’, downstream: 5’- 
CATCTGCTGGTACCACCAGTT-3’, amplified fragment for 
396 bp; ICAM1 primer: 5’-TTTTGGCTCGGAAGGTGG-3’ 
upstream, downstream 5’-TGTCGGATTGGAAGTGGC-3’, 
amplification product length 421 bp; Electrophoresis image 
was analyzed by using GelprO4 software, the average optical 
density value was set as representative density, on behalf 
of the corresponding amount of gene expression, and then 
divided by 毬-actin average optical density value, the 
results standed for the amplification product relative mRNA 
expression quantity.
2.4.4. Detection of lung tissue TNF-毩 and ICAM1 by 
Western blot method
  Western blot (5% gel) was carried out under 80 eV, using 
Odyssey for scan.
2.5. Statistical analysis
  SPSS 13.0 statistics software was used. Measurement 
data was analyzed with mean 依 SD, t test was carried out 
for groups comparation. P < 0.05 was regarded as having 
statistical significance.
3. Results
3.1. General and histological observation
  Normal lung’s appearance was pink, without obvious 
abnormal change. After LPS injection, lungs became dark 
red, volume and weight increased, with flake bleeding points 
in the visceral pleura, also with serious changes, like yellow 
or pale red liquid overflow. By light microscopy, alveolar 
structure in control group was clear and complete, without 
edema, inflammation pathological changes in alveolar, 
pulmonary interstitial, pulmonary vascular and bronchial 
(Figure 1). After LPS injection, alveolar lumen narrowed, 
alveolar wall blood capillary dilated, pulmonary interstitial 
inflammatory cell infiltrated, alveolar wall thickened, with 
pulmonary interstitial congestion and a small amount of 
bleeding in part of the alveolar cavity, as well as micro 
thrombus and formation of transparent membrane (Figure 2).
HE staining showed that in sevoflurane group, alveolar 
lumen narrowed, alveolar wall thickened, but the lesions 
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were significantly lighter than LPS group (Figure 3).
                                   
         
Figure 1. HE staining of control group.
         
Figure 2. HE staining of LPS group.
   
Figure 3. HE staining of sevoflurane group.
3.2. RT-PCR results
  Figure 4 and Table 1 shows that mRNA of TNF alpha and 
ICAM1 in LPS group was significantly higher than that of the 
control group (P<0.05), and mRNA of TNF alpha and ICAM1 
in sevoflurane group was significantly lower than LPS group 
(P<0.05). 
Table 1
mRNA detection results of TNF-毩 and ICAM1. 
Group TNF-毩 ICAM1
Control group 0.72依0.06 0.48依0.09
LPS group  1.53依0.18*  1.22依0.28*
Sevoflurane group   1.34依0.09**   0.94依0.03**
*P<0.05, compared with control group; **P<0.05. compared with 
LPS group.
Marker            1                2                   3
TNF- 毩(396 bp)
毬-actin (353 bp)
ICAM1 (421 bp)
毬-actin (353 bp)
Figure 4. mRNA expression results. 
1-control group; 2-LPS group; 3-sevoflurane group.
3.3. Westernblot results
  Figure 5 and Table 2 shows that protein banding imprinting 
of TNF alpha and ICAM1 in LPS treatment group was 
significantly higher than that of the control group and 
sevoflurane group (P<0.05).
Table 2
Protein expression results of TNF-毩 and ICAM1.
Group TNF-毩 ICAM1
Control group 107.36依7.91  97.23依2.03
LPS group  155.79依8.01* 135.37依6.02*
Sevoflurane group   123.55依5.47**  118.01依5.09**
*P<0.05, compared with control group; **P<0.05. compared with LPS 
group.
 
1                       2                  3
毬-actin 
TNF- 毩
ICAMI
 
Figure 5. Protein imprinting results.
1 control group; 2 LPS group; 3 sevoflurane group.
4. Discussion
   LPS is Gram negative bacteria cells outer membrane 
compos i t i on ,  ma in  pa thogen i c  compos i t i on  i s 
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lipopolysaccharide, can stimulate a variety of inflammatory 
medium to release. LPS can activate macrophages to release 
inflammatory medium, chemotaxis and arrest of neutrophils 
in the lungs, triggering local inflammatory reaction and 
produce lung injury,  LPS itself also have direct damage 
effect to lung epithelial and vascular endothelial, with the 
exact ALI model[8].
  Neutrophils gathered together in the alveoli in LPS rats, 
is early signal of pneumonia disease reaction. In the lungs 
and/or blood circulation, inflammatory factors such as 
TNF alpha and ICAM1 stimulate the polymorphonuclear 
leukocyte (PMN) to be seizured in pulmonary capillaries, 
then adhesive in endothelial and exit the pulmonary 
vascular bed with continuous activation, producing a 
large amount of cytokines, oxygen free radicals, hydrolytic 
enzyme and so on, causing diffuse alveolar damage, and 
ultimately lead to ALI. Migration of PMN from pulmonary 
vascular to the lung is a complicated process, involving 
adhesion molecules and chemokines[9], inhibit any link of 
process may affect PMN gathering. TNF alpha generated 
by the monocyte/macrophage during the first release of 
cytokines, is an important inflammation initialtion factor[10]. 
It can also increase cell adhesion molecule, and finally 
make inflammation cells to infiltrate through the tissue, then 
induce cell apoptosis.
  Sevoflurane is a common clinical inhalation anesthetics, 
pure use of sevoflurane inhalation has no effect to lung 
organization, but it can improve the endotoxin in lung injury. 
Research shows that seven halothane can relieve expression 
of TNF alpha in acute lung injury induced byendotoxin, 
mainly through reducing the release of some cell factor and 
chemical factor from alveolar macrophages[11]. Suter et al 
found that sevoflurane can reduce the lung tissue edema 
and inflammatory cell infiltration induced by endotoxin[12]. 
Voigtsberger et al[13] and Yue et al[14] respectively found that 
sevoflurane inhibited inflammatory reaction induced by LPS 
in acute lung injury. But the mechanism is still not clear, 
it may be through a variety of signaling pathways, such as 
PKC, myosin and phosphorylation and mitogen activated 
protein kinase MAPK pathway, working on the target point of 
pulmonary vascular endothelial cells and epithelial cell, and 
ultimately improve the lung tissue permeability, its specific 
regulatory mechanism needs to be further in-depth study.
  This research shows that pneumonia disease reaction in 
sevoflurane treatment group was significantly lower than the 
LPS group, indicating sevoflurane has certain inhibition to 
pneumonia disease reaction. But compared with the control 
group, there are still certain increases, indicating that 
sevoflurane can decrease the inflammatory cytokines release 
to certain degree, but still need to coordinate with other 
support treatments to fully improve lung function change.
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